Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997124

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Housing: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to promote public awareness of the the effect on people's health of poor quality indoor environments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184965
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Public Health England (PHE) raises public awareness of the impacts of indoor air pollution by supporting activities that aim to change behaviour, such as the annual Clean Air Day, and is working with health partners, such as the National Institute for Health and Care Excellence, World Health Organization and Allergy UK, to improve the evidence on the health impacts of poor indoor air quality which will enhance advice to the public. PHE also promotes awareness about carbon monoxide through the use of blog posts, press releases and social media updates.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 16:28:25 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1001904

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of how much medication errors have cost the NHS in each year for which information is available; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	188107
answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>The Department commissioned a study by the Policy Research Unit in Economic Evaluation of Health and Care Interventions on the prevalence and economic burden on medication errors in the National Health Service in England. Prevalence and Economic Burden of Medication Errors in the NHS in England was published in February 2018.</p><p> </p><p>This study estimated a range of costs to the NHS depending on which costs are included in the analysis. The range is from a baseline of £98.5 million per annum. The highest cost scenario has estimated costs to the NHS of £1.6 billion.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:42:40 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

1001913

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Public Health: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on substance misuse services of the removal of the ring fenced public health grant to local authorities in April 2019.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	188114
answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>I refer the hon. Member to the answer I gave on 6 November 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=QuestionsWithAnswersOnly&amp;house=commons&amp;use-dates=True&amp;answered-from=2014-06-04&amp;dept=17&amp;uin=185077" target="_blank">185077</a>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:29:00 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1001918

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	188233
answer	answer is ministerial correction date of answer 14/11/2018 answer text <p>Officials have had no such discussions. Health is a devolved matter and the availability of medicines for the treatment of rare diseases in Scotland is an issue for the Scottish Government.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/11/2018 11:21:33 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith

1001919

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.12 the UK Rare Diseases Strategy, what assessment his Department has made of whether the National Institute for Health and Care Excellence’s Single Technology Appraisal Programme meets the ambition of suitability for assessing rare disease treatments.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	188234
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Where a company is willing to set a fair price for a drug, the National Institute for Health and Care Excellence (NICE) technology appraisal process has been proven to be suitable for the assessment of drugs for rare diseases. NICE has been able to recommend a number of drugs for patients with rare diseases through its technology appraisal programme; recent examples include dinutuximab beta for neuroblastoma and daratumumab for relapsed and refractory multiple myeloma.</p><p> </p><p>With the aim of improving the lives of all those affected by a rare disease, the United Kingdom Government published the UK Strategy for Rare Diseases in 2013, a high-level framework containing 51 commitments which sets out a seven-year strategic vision (2013-2020). The Government is committed to implementing the Strategy’s commitments and has, in January 2018, published Implementation Plans setting out its actions for England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/11/2018 17:23:30 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith

1001923

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chelmsford Prison: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 October 2018 to Question 183583 on Health Service: Prisons, whether the Under-Secretary of State for Health met healthcare professionals on her visits to HMP Chelmsford.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	188121
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>I met with the Head of Healthcare and other healthcare professionals on my visit to HMP Chelmsford.</p><p> </p><p>During my visit to Ashworth High Security Hospital earlier this year I met with providers responsible for delivering healthcare services at HMP Liverpool.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 188122 question first answered 12/11/2018 15:46:31 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4036 label Biography information for Luciana Berger

999512

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heroin: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will allocate funding to local authorities that plan to implement heroin assisted treatment.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	187009
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Local authorities are responsible for making decisions on how to spend their allocation of the public health grant based on the needs of their local population. Local authorities are responsible for commissioning drug treatment to meet those needs, including heroin assisted treatment services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:08:16 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

999628

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 October 2018 to Question 183928 on Influenza: Vaccination, and with reference to the guidance, Flu Vaccination Programme Delivery Guidance 2018-19 published by NHS England, what assessment he has made of appropriateness of delivering aTIV to healthcare providers by mid-November.
tabling member constituency	Houghton and Sunderland South
tabling member printed	Bridget Phillipson
uin	187015
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>The adjuvanted trivalent flu vaccine is the recommended vaccine for those aged 65 years and over because it is a more effective vaccine for this age group and should offer better protection against flu compared to those previously used in the United Kingdom programme. This is explained in the Flu Vaccination Programme Delivery Guidance 2018-19 available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/flu-vaccination-programme-delivery-guidance-2018-19/" target="_blank">https://www.england.nhs.uk/publication/flu-vaccination-programme-delivery-guidance-2018-19/</a></p><p> </p><p>To ensure equitable access across the UK, deliveries of this vaccine are being phased between September and November. General practices and pharmacies were informed of the phased deliveries in April 2018 and given confirmed delivery dates in August. The supply to date has been on schedule.</p><p> </p><p>With appropriate planning, all eligible patients should be able to be offered vaccine before the flu season starts.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:13:14 answering member 4067 label Biography information for Steve Brine
tabling member	4046 label Biography information for Bridget Phillipson

999712

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 01 November 2018 to Question 185122 on In Vitro Fertilisation, if he will make an assessment of the potential merits of making mandatory National Institute for Health and Care Excellence guidelines on the assessment and treatment of people with fertility problems.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	187136
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>We have no such plans. The National Institute for Health and Care Excellence’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence. They focus on aspects of healthcare that are commissioned locally.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 06/11/2018 11:17:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4656 label Biography information for Layla Moran

997543

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department takes to (a) support fertility treatment in the NHS and (b) ensure NHS England and Clinical Commissioning Groups deliver fertility treatments in line with NICE guidelines.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	185587
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Clinical commissioning groups (CCGs) should have regard to the National Institute for Health and Care Excellence (NICE) guideline on the assessment and treatment of people with fertility problems when commissioning services for which they are responsible. This includes the recommendation in the guideline that three cycles of in-vitro fertilisation be offered to qualifying couples where the woman is under the age of 40 and one cycle where the woman is between the ages of 40 and 42.</p><p> </p><p>The NICE guideline is evidence based best practice for clinicians but is not mandatory. The availability of National Health Service funded fertility treatment is and always has been a matter for local determination. Decisions on the level of service provision are underpinned by clinical insight and knowledge of local healthcare needs and priorities.</p><p> </p><p>NHS England is currently undertaking a project to develop a benchmark price for NHS in-vitro fertilisation. This will help CCGs improve value for money in their commissioning. The Human Fertilisation and Embryology Authority are finalising some good practice advice for CCGs about the commissioning of fertility services, which should help improve the quality of commissioning decisions.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 06/11/2018 11:11:00 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4056 label Biography information for Nic Dakin